Symptomtext
patient receiving an expired dose of menactra, with no AE (adverse event); Initial information received on 05-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 11 years old male patient who received an expired dose of menactra, with no ae (adverse event) while receiving vaccine meningococcal a-c-y-w135 (d conj) vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine. On 03-May-2022, the patient received a 0.5ml dose of suspect meningococcal a-c-y-w135 (d conj) vaccine unknown formulation and strength lot U6919AB via intramuscular route in the left deltoid for prophylactic vaccination. Same day, the patient received an expired dose of menactra, with no ae (expired product administered). Action taken: Not applicable Corrective treatment: Not reported Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.